ADVISORY, Jan. 11, 2007 (PRIME NEWSWIRE) --
What: Daryl Faulkner, Chief Executive Officer of Digene Corporation (DIGE), will preside over the opening bell in honor of "Cervical Cancer Screening Month." Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Friday, January 12, 2007 at 9:30 a.m. ET Contacts: Albert Fleury 301.944.7028; albert.fleury@digene.com NASDAQ MarketSite: Jolene Libretto; 646.441.5220; mobile - 347.219.9539 Jolene.Libretto@NASDAQ.com
Feed Information:
The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
Webcast:
A live Webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Digene Corporation (DIGE):
A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests with a focus on women's health. The company's flagship product, The Digene(r) HPV Test is the only FDA-approved test for the human papillomavirus (HPV), the cause of cervical cancer. Rapidly emerging as a standard of practice in cervical cancer screening, the HPV test aids healthcare professionals in identifying women who are most at risk of having or developing cervical cancer, which today is the world's second-most-common type of cancer affecting women.
Digene's product portfolio also includes DNA tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Through its own staff or affiliated distributors, Digene markets its tests in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE.